Review



human primary peripheral blood cd4 + t cells  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc human primary peripheral blood cd4 + t cells
    Human Primary Peripheral Blood Cd4 + T Cells, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+primary+peripheral+blood+cd4+++t+cells/human+peripheral+blood+cd4++t+cells/pmc11927087-216-2-12
    Average 90 stars, based on 1 article reviews
    human primary peripheral blood cd4 + t cells - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells
    Article Snippet: The human primary peripheral blood CD4 + T cells (Cat. # 200–0165, Stemcell Technologies) were stimulated on a 96-well Nunc-Immuno Maxi Sorp plate precoated with soluble anti-CD3/CD28 antibodies in RPMI complete medium containing TGF-β1 (10 ng/ml), anti-human IL-12 (2 μg/ml), and anti-human IL-4 (R&D Systems) (1 μg/ml) for 3 days.

    Article Title: KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells.
    Article Snippet: The human primary peripheral blood CD4+ T cells (Cat. # 200-0165, Stemcell Technologies) were stimulated on a 96-well Nunc-Immuno Maxi Sorp plate precoated with soluble anti-CD3/CD28 antibodies in RPMI complete medium containing TGF-β1 (10 ng/ml), anti-human IL-12 (2 μg/ml), and anti-human IL-4 (R&D Systems) (1 μg/ml) for 3 days.

    Article Title: KDM5A/B promotes HIV-1 latency and KDM5 inhibitors promote HIV-1 lytic reactivation
    Article Snippet: The frozen Human primary peripheral blood CD4 + T cells (Cat. # 200-0165, Stemcell Technologies) were stimulated on a 96-well Nunc-Immuno Maxi Sorp plate precoated with soluble anti-CD3/CD28 antibodies in RPMI complete medium containing TGF-β1 (10 ng/ml), anti-human IL-12 (2 μg/ml), and anti-human IL-4 (R&D Systems) (1 μg/ml) for 3 days.

    Article Title: One-step generation of modular CAR-T with AAV-Cpf1
    Article Snippet: Human primary peripheral blood CD4 + T cells were acquired from healthy donors (STEMCELL Technologies).



    Similar Products

    human primary peripheral blood cd4 + t cells  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc human primary peripheral blood cd4 + t cells
    Human Primary Peripheral Blood Cd4 + T Cells, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+primary+peripheral+blood+cd4+++t+cells/human+peripheral+blood+cd4++t+cells/pmc11927087-216-2-12
    Average 90 stars, based on 1 article reviews
    human primary peripheral blood cd4 + t cells - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    primary human peripheral blood-derived cd4+ t cells stem cell  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc primary human peripheral blood-derived cd4+ t cells stem cell
    In vitro treatment of activated <t>CD4+</t> T cells with Y201 and Y202 EVs (n=2, mean events >18,000 counted) A) Proliferative cycles. B) Proliferative index C) Polarisation of activated T cells in the absence and presence of Y201 EVs and Y202 EVs (n=2, mean events >32,000 counted). D/E) Total peritoneal exudate cell (PEC) counts following zymosan (D) or schistosome egg (E) induced inflammation in the absence and presence of Y201 EVs and Y202 EVs. F/G) Examination of TCR+CD4+, naïve and central memory T cells in zymosan or schistosome egg induced inflammation in the absence and presence of Y201 EVs and Y202 EVs (n=3). One-Way ANOVA with Bonferroni post hoc testing,*p<0.05, **p<0.01, ***p<0.001.
    Primary Human Peripheral Blood Derived Cd4+ T Cells Stem Cell, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+primary+peripheral+blood+cd4+++t+cells/primary+human+peripheral+blood+derived+cd4++t+cells+stem+cell/bio_rxiv__2024__09__05__609844-177-22-25
    Average 90 stars, based on 1 article reviews
    primary human peripheral blood-derived cd4+ t cells stem cell - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human primary peripheral blood cd4+ t cells cat. # 200-0165  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc human primary peripheral blood cd4+ t cells cat. # 200-0165
    In vitro treatment of activated <t>CD4+</t> T cells with Y201 and Y202 EVs (n=2, mean events >18,000 counted) A) Proliferative cycles. B) Proliferative index C) Polarisation of activated T cells in the absence and presence of Y201 EVs and Y202 EVs (n=2, mean events >32,000 counted). D/E) Total peritoneal exudate cell (PEC) counts following zymosan (D) or schistosome egg (E) induced inflammation in the absence and presence of Y201 EVs and Y202 EVs. F/G) Examination of TCR+CD4+, naïve and central memory T cells in zymosan or schistosome egg induced inflammation in the absence and presence of Y201 EVs and Y202 EVs (n=3). One-Way ANOVA with Bonferroni post hoc testing,*p<0.05, **p<0.01, ***p<0.001.
    Human Primary Peripheral Blood Cd4+ T Cells Cat. # 200 0165, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+primary+peripheral+blood+cd4+++t+cells/human+primary+peripheral+blood+cd4++t+cells+cat++++200+0165/pm38925368-241-2-11
    Average 90 stars, based on 1 article reviews
    human primary peripheral blood cd4+ t cells cat. # 200-0165 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro treatment of activated CD4+ T cells with Y201 and Y202 EVs (n=2, mean events >18,000 counted) A) Proliferative cycles. B) Proliferative index C) Polarisation of activated T cells in the absence and presence of Y201 EVs and Y202 EVs (n=2, mean events >32,000 counted). D/E) Total peritoneal exudate cell (PEC) counts following zymosan (D) or schistosome egg (E) induced inflammation in the absence and presence of Y201 EVs and Y202 EVs. F/G) Examination of TCR+CD4+, naïve and central memory T cells in zymosan or schistosome egg induced inflammation in the absence and presence of Y201 EVs and Y202 EVs (n=3). One-Way ANOVA with Bonferroni post hoc testing,*p<0.05, **p<0.01, ***p<0.001.

    Journal: bioRxiv

    Article Title: Extracellular vesicle bioactivity and potential clinical utility is determined by mesenchymal stromal cell clonal subtype

    doi: 10.1101/2024.09.05.609844

    Figure Lengend Snippet: In vitro treatment of activated CD4+ T cells with Y201 and Y202 EVs (n=2, mean events >18,000 counted) A) Proliferative cycles. B) Proliferative index C) Polarisation of activated T cells in the absence and presence of Y201 EVs and Y202 EVs (n=2, mean events >32,000 counted). D/E) Total peritoneal exudate cell (PEC) counts following zymosan (D) or schistosome egg (E) induced inflammation in the absence and presence of Y201 EVs and Y202 EVs. F/G) Examination of TCR+CD4+, naïve and central memory T cells in zymosan or schistosome egg induced inflammation in the absence and presence of Y201 EVs and Y202 EVs (n=3). One-Way ANOVA with Bonferroni post hoc testing,*p<0.05, **p<0.01, ***p<0.001.

    Article Snippet: To determine MSC-derived EV immunomodulation for deactivation and suppression of T cell proliferation, suspension cultures of 1.0×10 5 primary human peripheral blood-derived CD4+ T cells (Stem Cell Technologies) were grown in RPMI-1640 with 10% FBS 1% P/S (Gibco, Cat: 10363083) and were pre-treated for 6hrs with 20X EVs isolated from serum-free conditioned medium collected over 24hrs culture from 2.0×10 6 of Y201 or Y202 MSCs.

    Techniques: In Vitro